NCT00307996

Brief Summary

The purpose of this study is to examine whether CoQ10 administration is effective as an antioxidant in hemodialysis patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Mar 2004

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2004

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2004

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

March 27, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 28, 2006

Completed
Last Updated

March 28, 2006

Status Verified

March 1, 2006

First QC Date

March 27, 2006

Last Update Submit

March 27, 2006

Conditions

Chronic Renal FailureHemodialysis

Keywords

CoQ10hemodialysisoxidative markerantioxidant

Outcome Measures

Primary Outcomes (2)

  • Oxidative protein concentration at 6 month

  • Antioxidant capacity at 6 month

Interventions

Coenzyme Q10 (drug)DRUG

Eligibility Criteria

Age0 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • hemodialysis for at least 6 months

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Iwata City Hospital

Iwata, Shizuoka, 438-8550, Japan

Location

MeSH Terms

Conditions

Kidney Failure, Chronic

Interventions

coenzyme Q10Pharmaceutical Preparations

Condition Hierarchy (Ancestors)

Renal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Hiromichi Kumagai, MD

    University of Shizuoka

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

March 27, 2006

First Posted

March 28, 2006

Study Start

March 1, 2004

Study Completion

December 1, 2004

Last Updated

March 28, 2006

Record last verified: 2006-03

Locations

JP(1)